BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24219293)

  • 1. Intron retention: a human DKC1 gene common splicing event.
    Turano M; Angrisani A; Di Maio N; Furia M
    Biochem Cell Biol; 2013 Dec; 91(6):506-12. PubMed ID: 24219293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new human dyskerin isoform with cytoplasmic localization.
    Angrisani A; Turano M; Paparo L; Di Mauro C; Furia M
    Biochim Biophys Acta; 2011 Dec; 1810(12):1361-8. PubMed ID: 21820037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
    Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
    Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress regarding snoRNA biogenesis and function].
    Sasaki YT; Hirose T
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2436-42. PubMed ID: 17471960
    [No Abstract]   [Full Text] [Related]  

  • 6. Human dyskerin: beyond telomeres.
    Angrisani A; Vicidomini R; Turano M; Furia M
    Biol Chem; 2014 Jun; 395(6):593-610. PubMed ID: 24468621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel alternative splice variants of human SAMD11.
    Jin G; Long C; Liu W; Tang Y; Zhu Y; Zhou X; Ai Y; Zhang Q; Shen H
    Gene; 2013 Nov; 530(2):215-21. PubMed ID: 23978614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita.
    Hiramatsu H; Fujii T; Kitoh T; Sawada M; Osaka M; Koami K; Irino T; Miyajima T; Ito M; Sugiyama T; Okuno T
    Pediatr Hematol Oncol; 2002 Sep; 19(6):413-9. PubMed ID: 12186364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
    De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
    Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intron retention generates ANKRD1 splice variants that are co-regulated with the main transcript in normal and failing myocardium.
    Torrado M; Iglesias R; Nespereira B; Centeno A; López E; Mikhailov AT
    Gene; 2009 Jul; 440(1-2):28-41. PubMed ID: 19341785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant dyskerin ends relationship with telomerase.
    Shay JW; Wright WE
    Science; 1999 Dec; 286(5448):2284-5. PubMed ID: 10636790
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
    He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
    Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations of the DKC1 gene in individuals affected with dyskeratosis congenita.
    Rostamiani K; Klauck SM; Heiss N; Poustka A; Khaleghi M; Rosales R; Metzenberg AB
    Blood Cells Mol Dis; 2010; 44(2):88. PubMed ID: 19879169
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a novel mutation in DKC1 in dyskeratosis congenita.
    Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D
    Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late presentation of X-linked dyskeratosis congenita with a missense mutation in codon 350 of the dyskerin protein.
    Mori N; Makino T; Mizawa M; Kagoyama K; Kanegane H; Sakaguchi H; Miyazono T; Kojima S; Shimizu T
    Eur J Dermatol; 2015; 25(1):75-6. PubMed ID: 25499969
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissecting dyskeratosis.
    Meier UT
    Nat Genet; 2003 Feb; 33(2):116-7. PubMed ID: 12560816
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
    Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
    BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.